Company performance
Add to research
Current Price
as of Feb 13, 2025$157.25
P/E Ratio
27.16
Market Cap
$378.6B
Description
Add to research
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.
Metrics
Add to research
Overview
- HQNew Brunswick, NJ
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerJNJ
- Price$157.25+1.28%
Trading Information
- Market cap$378.60B
- Float99.87%
- Average Daily Volume (1m)9,397,943
- Average Daily Volume (3m)8,747,133
- EPS$5.84
Company
- Revenue$88.82B
- Rev growth (1yr)4.31%
- Net income$14.07B
- Gross margin68.63%
- EBITDA margin31.71%
- EBITDA$28.16B
- EV$364.65B
- EV/Revenue4.11
- P/E27.16
- P/S4.30
- P/B5.40
- Debt/Equity52.92
Documents
Add to research
SEC Filings
Earnings Calls
Factset Street Account
Johnson & Johnson initiated outperform at RBC Capital Markets ($155.52, 0.00) (2023-10-05T02:49:17Z)
Wikipedia